“…31 Overall, 2/5 (40%) clinical studies featured outcomes related to an microbial effec veness (including treatment or preven on), 27,30 2/5 (40%) studies featured outcomes related to wound progression or healing, 28,30 and 2/5 (40%) study included outcomes related to cost-effec veness. 28,29 Of the laboratory studies, 2/4 (50%) studies demonstrated the effects of DACC-coated dressing bacteria, 32,33 2/4 (50%) studies detailed the effect of the dressing on cells important on the wound healing response (kera nocytes, fibroblasts, and macrophages), 33,34 and 1/4 (25%) study describes the interac on between DACC-coated dressing and bacterially produced and clinically important endotoxin. 35 The in vitro and clinical evidence iden fied for this review update are summarised in Tables 1 and 2, respec vely.…”